期刊
DIABETES RESEARCH AND CLINICAL PRACTICE
卷 142, 期 -, 页码 195-202出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.diabres.2018.05.041
关键词
Hyperinsulinemia; Muscle atrophy; Myostatin; Obesity
资金
- Ministry of Education, Culture, Sports, Science, and Technology of Japan [JP16K09276, JP15K08211, JP16K08959, JP16H07498, JP16K19549, JP17K09827, JP15K08634, JP18H02737]
- Nakatomi Foundation
- Kao Research Council for the Study of Healthcare Science
- National Hospital Organization [H26-NHO-02]
Aims: The protein myostatin is a member of the transforming growth factor beta superfamily. This is mainly expressed in skeletal muscle and negatively regulates skeletal muscle growth. The present study aimed to elucidate the associations among circulating myostatin level, skeletal muscle mass, and metabolic profiles in Japanese obese patients. Methods: Japanese obese outpatients (n = 74) were enrolled. We measured clinical parameters, quantified serum myostatin levels, and examined their associations in a crosssectional manner. Results: Both total skeletal muscle mass and serum myostatin level were higher in males than in females. Among 74 patients, serum myostatin level was positively correlated with skeletal muscle mass and serum immunoreactive insulin (IRI) level [correlation coefficient (r) = 0.294, P = 0.011; r = 0.262, P = 0.024, respectively]. Furthermore, multivariate linear regression analysis revealed that serum myostatin level was positively correlated with IRI after adjusting for gender and skeletal muscle mass (beta-coefficient = 0.230, P = 0.029, R2 = 0.236). Conclusions: In obese patients, serum myostatin level was elevated in conjunction with an increase in IRI level independent of skeletal muscle mass. This may imply possible novel pathological implications of serum myostatin in muscle mass and metabolism in obese patients with hyperinsulinemia. (C) 2018 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据